{"id":70,"date":"2023-03-30T14:12:07","date_gmt":"2023-03-30T13:12:07","guid":{"rendered":"http:\/\/molecularhealth.com\/eu\/?page_id=70"},"modified":"2026-02-11T14:20:28","modified_gmt":"2026-02-11T14:20:28","slug":"news","status":"publish","type":"page","link":"https:\/\/molecularhealth.com\/eu\/news\/","title":{"rendered":"News"},"content":{"rendered":"
\r\n
\r\n
\r\n
\r\n \r\n
\r\n

News and Events
Stay abreast with
company news \r\n <\/h1>\r\n <\/div>\r\n \r\n
<\/i> Have a question?<\/span><\/a><\/div> <\/span>\r\n <\/div>\r\n\r\n \r\n <\/div>\r\n<\/div>\r\n<\/div>\n\n\n

News and press releases<\/h2>\n\n\n
\r\n\r\n\t\r\n\t\t\t\t
\r\n\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

Pairing data-driven clinical-molecular insights with biological validation to identify relevant drug targets and confirm leads for biopharmaceutical companies Milan, Italy and Heidelberg, Germany \u2013 June 4, 2025 \u2013 Axxam S.p.A., a premier provider of integrated early discovery services, and Molecular Health GmbH, a leader in artificial intelligence (AI)-driven development solutions, are announcing a strategic collaboration […]<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t\r\n\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

Integrated DNA Technologies and Molecular Health Ink Commercial Partnership<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

CORALVILLE, Iowa and HEIDELBERG, Germany (May 15, 2024)\u2014Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities. The partnership pairs IDT\u2019s Archer NGS research assay platform with Molecular Health\u2019s variant annotation and reporting software […]<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t\r\n\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

St. Marianna University School of Medicine in Japan relies on MH Guide for personalized cancer medicine<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

Heidelberg, Germany\/Kawasaki, Japan, October 27, 2023 \u2013 St. Marianna University School of Medicine in Kawasaki, Japan, will utilize MH Guide to personalize cancer treatment. The agreement between University School of Medicine and Molecular Health resulted from a preceding study partnership.The MH Guide system has been previously implemented at St. Marianna University Hospital, and a proof-of-concept […]<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t\r\n\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

Molecular Health and Takara Bio collaborate to support Genome Medicine in Japan<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

Collaboration to introduce whole-genome sequencing with comprehensive variant annotation for Japanese patients affected by hereditary diseases.<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t\r\n\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

Molecular Health receives IVDR certification for MH Guide<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

Molecular Health received certification from the European Union for its MH Guide clinical decision support software under the new In Vitro Diagnostics Regulation (EU) 2017\/746 (IVDR).<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t\r\n\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\t\t\t\t\t

Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions<\/h2>\t\t\t\t\t
\r\n\t\t\t\t\t\t

Molecular Health, the University of Florida, Takeda Oncology, and thinkQ2 published a triad of articles proving a novel systems approach to elucidate mechanisms of drug toxicities.<\/p>\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/i> \t\t\t\t\tRead more\t\t\t\t\t\t<\/span><\/a>\t\t\t\t<\/div>\r\n\r\n\t\t\t\t

1<\/span>\n2<\/a>\nNext »<\/a><\/div>\t\t<\/div>\r\n\t\t\t\t\r\n<\/div><\/div>\n\n\n

Events <\/h2>\n\n\n\n
Upcoming Events 2026<\/th>When<\/th>Where<\/th><\/tr><\/thead>
109th Annual Meeting of the German Society of Pathology (DGP)<\/a><\/td>28-30 May<\/td>Augsburg, DE<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
Past Events <\/th>When<\/th>Where<\/th><\/tr><\/thead>
Lunch & Learn Webinar (only in German)<\/a>
“Integrierte, zielgerichtete Therapieempfehlungen im molekularpathologischen Befund<\/a>“<\/strong><\/td>		17 Sep 2024<\/td>online<\/td><\/tr>
Live-Seminar (only in German)<\/a>
“Rare tumors, challenges in clinical <\/a>and diagnostic practice”<\/a><\/strong> (CME webinar<\/a>)<\/td>		13 Mar 2024<\/td>Online<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\n
<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

News and press releases Events Upcoming Events 2026 When Where 109th Annual Meeting of the German Society of Pathology (DGP) 28-30 May Augsburg, DE Past Events When Where Lunch & Learn Webinar (only in German)“Integrierte, zielgerichtete Therapieempfehlungen im molekularpathologischen Befund“ 17 Sep 2024 online Live-Seminar (only in German)“Rare tumors, challenges in clinical and diagnostic practice” […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":5000,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"class_list":["post-70","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/70","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/comments?post=70"}],"version-history":[{"count":81,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/70\/revisions"}],"predecessor-version":[{"id":4383,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/70\/revisions\/4383"}],"wp:attachment":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/media?parent=70"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}